Characterization and validation of OCT biomarkers in eyes treated for retinopathy of prematurity with laser or intravitreal bevacizumab
Research Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
VitreoRetinal Surgery Foundation
Start Date
December 1, 2024
End Date
October 31, 2025
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
VitreoRetinal Surgery Foundation
Start Date
December 1, 2024
End Date
October 31, 2025